A plain language summary describing changes in pain associated with uterine fibroids among women receiving relugolix combination therapy.
A plain language summary describing changes in pain associated with uterine fibroids among women receiving relugolix combination therapy. Pain Manag. 2024 Oct 28; 1-8.
PMID: 39466126Regulatory roles of NAMPT and NAD+ metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment.
Regulatory roles of NAMPT and NAD+ metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment. Redox Biol. 2024 Oct 26; 78:103411.
PMID: 39486360Associations Between Earlier Menarche and Fibroid Severity in Individuals Seeking Hysterectomy.
Associations Between Earlier Menarche and Fibroid Severity in Individuals Seeking Hysterectomy. J Womens Health (Larchmt). 2024 Oct 15.
PMID: 39405329Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma.
Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma. Cells. 2024 Aug 28; 13(17).
PMID: 39273015Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies.
Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies. Expert Opin Ther Targets. 2024 Aug; 28(8):669-687.
PMID: 39136530Surgical myomectomy followed by oral Myfembree vs standard of care (SOUL trial): Study protocol for a randomized control trial.
Surgical myomectomy followed by oral Myfembree vs standard of care (SOUL trial): Study protocol for a randomized control trial. PLoS One. 2024; 19(7):e0306053.
PMID: 38954680Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary.
Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. J Comp Eff Res. 2024 08; 13(8):e230194.
PMID: 38934918Exosome Therapy: A Novel Approach for Enhancing Estrogen Levels in Perimenopause.
Exosome Therapy: A Novel Approach for Enhancing Estrogen Levels in Perimenopause. Int J Mol Sci. 2024 Jun 27; 25(13).
PMID: 39000181Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.
Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy. Cells. 2024 Jun 26; 13(13).
PMID: 38994959Targeting Bromodomain-Containing Protein 9 in Human Uterine Fibroid Cells.
View All Publications
Targeting Bromodomain-Containing Protein 9 in Human Uterine Fibroid Cells. Reprod Sci. 2024 Jun 10.
PMID: 38858328
People
Ayman Al-Hendy, MD PhD
- Professor of Obstetrics and Gynecology
- Websites: Research Network Profile
- Contact: aalhendy@uchicago.edu